Noticias de SNY_US

Noticias del mercado

Últimas noticias sobre SNY_US — 317 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SNY_US ✕ 317 resultados
16/04/2026 SNY_US — Medical Marketing and Media
The Escalator: Sanofi, Merck, Novo Nordisk and more
16/04/2026 SNY_US — Yahoo Finance
Sanofi Expands Immunology Footprint With New Approvals And Respiratory Data
15/04/2026 SNY_US — Oncology Pipeline
Sanofi and Pfizer get another conjugate blow | ApexOnco - Clinical Trials news and analysis
14/04/2026 SNY_US — GlobeNewswire
Sanofi: Information concerning the total number of voting rights and shares - March 2026
13/04/2026 SNY_US — Fox Business
Merck, Sanofi are latest companies to add medications to TrumpRx
12/04/2026 SNY_US — Yahoo Finance
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
08/04/2026 SNY_US — Yahoo Finance
Sanofi - Combined General Meeting of April 29, 2026 - Availability of Preparatory documents
07/04/2026 SNY_US — Clinical Trials Arena
Sanofi’s bispecific scores in respiratory diseases but fails in eczema
07/04/2026 SNY_US — Fierce Biotech
Sanofi’s bispecific scores double respiratory phase 2 wins, but flunks eczema study
07/04/2026 SNY_US — BioSpace
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
07/04/2026 SNY_US — BioPharma Dive
Sanofi immune drug hopeful posts mixed results in mid-stage tests
07/04/2026 SNY_US — Yahoo Finance
Is It Time To Reconsider Sanofi (ENXTPA:SAN) After Recent Share Price Weakness?
07/04/2026 SNY_US — FirstWord Pharma
Sanofi's lunsekimig scores dual mid-stage wins in respiratory trials, stumbles in dermatitis
06/04/2026 SNY_US — Fierce Pharma
With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine
03/04/2026 SNY_US — Sanofi
The Fast (And Intense) Lane: How Expedited Approvals Are Going Further and Faster for Patients
02/04/2026 SNY_US — Fierce Pharma
German CDMO Adragos buys French sterile injectables plant from Sanofi
31/03/2026 SNY_US — BioSpace
AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases
30/03/2026 SNY_US — BioPharma Dive
Sanofi eczema drug weighed down by mixed results, safety concerns
30/03/2026 SNY_US — Yahoo Finance
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
30/03/2026 SNY_US — Yahoo Finance
Sanofi Oncology And Rare Disease Updates Spark Fresh Valuation Interest

Página 14 de 16

keyboard_arrow_up